secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2021-12-14T23:59:59+00:00
Accession:  0001570562-21-000177
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus enters $125M credit facility with Pharmakon Advisors; initial $75M draw
------------------------------------------------------------------------------

- $75M drawn at close; up to $50M additional tranche available until Dec 31, 2022.
- Facility matures in 6 years, interest-only for first 39 months; rate = 3-month LIBOR (1% floor) + 8.5%.
- Proceeds for general corporate, working capital, and potential strategic transactions.
- Company expects initial tranche to fund operations beyond cash flow breakeven, removing near-term equity dilution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056221000177/0001570562-21-000177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056221000177/eols-20211214.htm
  HTML page:      https://secwatch.observer/filing/0001570562-21-000177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer